RPL32P3 and cancer: The results demonstrated that SNORA7B was up-regulated in all BC cell lines compared with its expression in normal breast cell line MCF10A, while RPL32P3 was overexpressed in only two cancer cell lines compared to MCF10A (Fig. 2b, c).